Do this Before Elon’s Reveal on January 22nd

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

IONS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.71%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $12,290,619.63

Ionis Pharmaceuticals Insider Trading History Chart

Ionis Pharmaceuticals Share Price & Price History

^$37.68

▼ -0.42 (-1.10%)

As of 12/17/2024 01:00 AM ET

Days: 30 | 90 | 365

The #1 Crypto for AI

From Weiss Ratings | Ad

We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”

Learn more about it by watching THIS NOW.

Ionis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/12/2024	Brett P. Monia	CEO	Sell	6,630	$38.05	$252,271.50	167,393
11/12/2024	Eric Swayze	EVP	Sell	1,194	$37.92	$45,276.48	33,713
10/16/2024	Eric Swayze	EVP	Sell	53	$38.31	$2,030.43	157
8/28/2024	Richard S. Geary	EVP	Sell	320	$49.16	$15,731.20	85,154
8/5/2024	Richard S. Geary	EVP	Sell	2,430	$48.00	$116,640.00	85,508
7/16/2024	Joseph Klein, III	Director	Sell	12,000	$50.00	$600,000.00	16,346
5/3/2024	Joseph Klein, III	Director	Sell	6,000	$42.71	$256,260.00	16,346
4/16/2024	Joseph Baroldi	EVP	Sell	4,006	$41.60	$166,649.60	19,631
2/16/2024	Brett P. Monia	CEO	Sell	387	$44.49	$17,217.63	173,751
2/2/2024	Brett P. Monia	CEO	Sell	23,501	$49.37	$1,160,244.37	174,138
2/2/2024	Elizabeth L. Hougen	CFO	Sell	2,125	$49.54	$105,272.50	92,905
2/2/2024	Eric Swayze	EVP	Sell	1,907	$49.56	$94,510.92	34,324
1/31/2024	Eric Swayze	EVP	Sell	10,773	$52.00	$560,196.00	32,516
1/25/2024	Brett P. Monia	CEO	Sell	2,285	$51.75	$118,248.75	151,851
1/25/2024	Patrick R. O'Neil	EVP	Sell	6,450	$51.75	$333,787.50	46,802
1/17/2024	Brett P. Monia	CEO	Sell	32,059	$50.42	$1,616,414.78	154,136
1/17/2024	Elizabeth L. Hougen	CFO	Sell	8,683	$50.42	$437,796.86	90,890
1/17/2024	Onaiza J. Cadoret-Manier	EVP	Sell	5,564	$50.42	$280,536.88	33,810
1/12/2024	Eugene Schneider	EVP	Sell	8,000	$53.50	$428,000.00	38,170
12/28/2023	B. Lynne Parshall, Esq.	Director	Sell	42,525	$50.19	$2,134,329.75	82,588
12/26/2023	B. Lynne Parshall, Esq.	Director	Sell	25,113	$51.46	$1,292,314.98	82,588
12/26/2023	Patrick R. O'Neil	EVP	Sell	20,825	$51.46	$1,071,654.50	40,355
12/21/2023	Brett P. Monia	CEO	Sell	17,500	$49.29	$862,575.00	118,111
12/20/2023	C. Frank Bennett	EVP	Sell	6,500	$49.64	$322,660.00	65,754
12/14/2023	Brett P. Monia	CEO	Sell	24,000	$49.58	$1,189,920.00	118,111
11/15/2023	Joseph Klein, III	Director	Sell	2,000	$50.00	$100,000.00	16,346
10/17/2023	Eric Swayze	EVP	Sell	52	$47.95	$2,493.40	73
10/12/2023	Brett P. Monia	CEO	Sell	3,770	$46.00	$173,420.00	118,111
9/28/2023	C. Frank Bennett	EVP	Sell	4,460	$46.50	$207,390.00	65,754
9/26/2023	B. Lynne Parshall, Esq.	Director	Sell	10,000	$45.13	$451,300.00	82,588
8/1/2023	Allene M. Diaz	Director	Sell	657	$41.05	$26,969.85	12,676
7/18/2023	Joseph Klein, III	Director	Sell	3,555	$42.00	$149,310.00	20,346
7/7/2023	Brett P. Monia	CEO	Sell	18,650	$42.25	$787,962.50	121,724
5/24/2023	Patrick R. O'Neil	EVP	Sell	1,527	$41.70	$63,675.90	40,355
5/22/2023	Brett P. Monia	CEO	Sell	4,931	$40.14	$197,930.34	140,374
4/18/2023	Brian Birchler	EVP	Sell	672	$36.50	$24,528.00	36,528
2/6/2023	Brett P. Monia	CEO	Sell	24,651	$40.69	$1,003,049.19	145,305
2/6/2023	Elizabeth L. Hougen	CFO	Sell	2,079	$40.59	$84,386.61	75,496
2/6/2023	Eric Swayze	EVP	Sell	1,815	$40.79	$74,033.85	31,941
1/30/2023	Patrick R. O'Neil	EVP	Sell	4,500	$39.42	$177,390.00	44,179
1/18/2023	Brett P. Monia	CEO	Sell	25,066	$39.49	$989,856.34	120,863
1/18/2023	Elizabeth L. Hougen	CFO	Sell	8,280	$39.70	$328,716.00	73,435
1/18/2023	Eric Swayze	EVP	Sell	5,631	$39.74	$223,775.94	30,041
1/17/2023	Joseph Klein, III	Director	Sell	2,000	$40.00	$80,000.00	16,791
9/8/2022	Eric Swayze	EVP	Sell	460	$44.55	$20,493.00	19,892
7/15/2022	Joseph Klein, III	Director	Sell	1,333	$38.24	$50,973.92	18,791
4/21/2022	Eric Swayze	EVP	Sell	378	$44.15	$16,688.70	20,353
4/12/2022	Patrick R. O'Neil	EVP	Sell	6,792	$40.06	$272,087.52	34,536
4/1/2022	Brett P. Monia	CEO	Sell	355	$37.49	$13,308.95	88,662

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad

Discover our #1 crypto for the Trump Presidency Bull Run now! (Available for a Short Time) We highly recommend this hot altcoin before prices get too high

Check it out by going here now

SEC Filings (Institutional Ownership Changes) for Ionis Pharmaceuticals (NASDAQ:IONS)

93.86% of Ionis Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ionis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2024	Sanctuary Advisors LLC	9,277	$0.37M	0.0%	-43.6%	0.006%
11/16/2024	Geode Capital Management LLC	2,668,358	$106.92M	0.0%	+7.4%	1.690%
11/15/2024	Public Employees Retirement System of Ohio	56,825	$2.28M	0.0%	+2.8%	0.036%
11/15/2024	Groupama Asset Managment	916,060	$0.37M	0.0%	+4.1%	0.580%
11/15/2024	Y Intercept Hong Kong Ltd	20,141	$0.81M	0.0%	N/A	0.013%
11/15/2024	XTX Topco Ltd	16,805	$0.67M	0.0%	N/A	0.011%
11/15/2024	Two Sigma Advisers LP	1,332,411	$53.38M	0.1%	+3.5%	0.844%
11/15/2024	Sphera Funds Management LTD.	63,821	$2.56M	0.4%	-54.5%	0.040%
11/15/2024	Stifel Financial Corp	182,505	$7.31M	0.0%	-15.6%	0.116%
11/15/2024	Itau Unibanco Holding S.A.	1,081	$43K	0.0%	+40.9%	0.001%
11/15/2024	Jacobs Levy Equity Management Inc.	650,779	$26.07M	0.1%	+13.6%	0.412%
11/15/2024	Harbor Advisors LLC	5,500	$0.22M	0.0%	N/A	0.003%
11/15/2024	Baker BROS. Advisors LP	223,470	$8.95M	0.1%	N/A	0.142%
11/15/2024	Erste Asset Management GmbH	51,300	$2.10M	0.0%	N/A	0.032%
11/14/2024	Bellevue Group AG	7,874,400	$315.45M	5.1%	-4.7%	4.987%
11/14/2024	HBK Investments L P	60,000	$2.40M	0.0%	N/A	0.038%
11/14/2024	Castle Hook Partners LP	23,940	$0.96M	0.0%	N/A	0.015%
11/14/2024	FORA Capital LLC	5,081	$0.20M	0.0%	N/A	0.003%
11/14/2024	MetLife Investment Management LLC	9,363	$0.38M	0.0%	+5.8%	0.006%
11/13/2024	Great Point Partners LLC	255,000	$10.22M	3.0%	-22.7%	0.161%
11/13/2024	Quantbot Technologies LP	1,267	$51K	0.0%	N/A	0.001%
11/13/2024	The Manufacturers Life Insurance Company	308,947	$12.38M	0.0%	+12.4%	0.196%
11/13/2024	Horizon Kinetics Asset Management LLC	11,952	$0.48M	0.0%	-4.2%	0.008%
11/12/2024	Algert Global LLC	45,430	$1.82M	0.0%	-39.7%	0.029%
11/12/2024	HealthInvest Partners AB	82,691	$3.31M	1.6%	+103.2%	0.052%
11/12/2024	Charles Schwab Investment Management Inc.	1,443,020	$57.81M	0.0%	+8.7%	0.914%
11/9/2024	Landscape Capital Management L.L.C.	25,435	$1.02M	0.1%	N/A	0.017%
11/8/2024	Grandfield & Dodd LLC	34,813	$1.40M	0.1%	+2.2%	0.024%
11/8/2024	Advisors Asset Management Inc.	6,140	$0.25M	0.0%	+21.0%	0.004%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	17,741	$0.71M	0.0%	-59.9%	0.012%
11/8/2024	Commerce Bank	77,553	$3.11M	0.0%	+1.6%	0.053%
11/8/2024	Prospera Private Wealth LLC	1,049	$42K	0.0%	N/A	0.001%
11/7/2024	Quest Partners LLC	2,674	$0.11M	0.0%	+94.8%	0.002%
11/7/2024	Swiss National Bank	256,600	$10.28M	0.0%	-0.5%	0.176%
11/6/2024	Natixis Advisors LLC	21,080	$0.84M	0.0%	-9.9%	0.014%
11/6/2024	Nicollet Investment Management Inc.	20,402	$0.82M	0.3%	+1.5%	0.014%
11/6/2024	Nicola Wealth Management LTD.	87,000	$3.49M	0.3%	+17.6%	0.060%
11/5/2024	Victory Capital Management Inc.	18,350	$0.74M	0.0%	+5.9%	0.013%
11/5/2024	Aigen Investment Management LP	11,612	$0.47M	0.1%	N/A	0.008%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	196,114	$7.86M	0.0%	-1.6%	0.134%
11/5/2024	Baillie Gifford & Co.	39,581	$1.59M	0.0%	-84.8%	0.027%
11/4/2024	State of New Jersey Common Pension Fund D	51,775	$2.07M	0.0%	-6.5%	0.035%
11/2/2024	Privium Fund Management B.V.	250,744	$10.05M	2.5%	+1.4%	0.171%
11/1/2024	Capital Performance Advisors LLP	1,000	$40K	0.0%	N/A	0.001%
10/31/2024	ARK Investment Management LLC	1,384,269	$55.45M	0.5%	+1.7%	0.948%
10/31/2024	Principal Financial Group Inc.	13,112	$0.53M	0.0%	-24.9%	0.009%
10/30/2024	Amalgamated Bank	9,957	$0.40M	0.0%	+3.1%	0.007%
10/29/2024	Van ECK Associates Corp	59,006	$2.27M	0.0%	+17.4%	0.040%
10/25/2024	China Universal Asset Management Co. Ltd.	28,121	$1.13M	0.1%	+64.0%	0.019%
10/25/2024	abrdn plc	303,274	$12.06M	0.0%	+22.8%	0.208%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	5,288	$0.22M	0.0%	+21.3%	0.004%
10/23/2024	Assenagon Asset Management S.A.	13,298	$0.53M	0.0%	-45.1%	0.009%
10/22/2024	International Assets Investment Management LLC	328,772	$13.17M	0.0%	+3,287.0%	0.225%
10/22/2024	Private Advisor Group LLC	43,787	$1.75M	0.0%	-5.7%	0.030%
10/22/2024	BLB&B Advisors LLC	152,250	$6.10M	0.3%	-1.0%	0.104%
10/16/2024	Bleakley Financial Group LLC	16,678	$0.67M	0.0%	+2.1%	0.011%
10/16/2024	Vontobel Holding Ltd.	5,502	$0.22M	0.0%	-31.1%	0.004%
10/11/2024	Creative Planning	28,382	$1.14M	0.0%	+5.7%	0.019%
10/8/2024	CWM LLC	1,741	$70K	0.0%	-21.5%	0.001%
10/7/2024	GAMMA Investing LLC	664	$27K	0.0%	+83.9%	0.000%
10/5/2024	Handelsbanken Fonder AB	43,011	$1.72M	0.0%	+26.8%	0.029%
10/3/2024	SG Americas Securities LLC	7,419	$0.30M	0.0%	N/A	0.005%
9/5/2024	Sanctuary Advisors LLC	16,441	$0.78M	0.0%	N/A	0.011%
8/27/2024	Clearbridge Investments LLC	2,160,270	$102.96M	0.1%	-51.6%	1.480%
8/21/2024	Truist Financial Corp	8,003	$0.38M	0.0%	-15.7%	0.005%
8/19/2024	Point72 Asset Management L.P.	137,210	$6.54M	0.0%	-52.1%	0.094%
8/16/2024	Algert Global LLC	75,350	$3.59M	0.1%	+149.2%	0.052%
8/15/2024	Susquehanna Portfolio Strategies LLC	43,028	$2.05M	0.1%	-67.2%	0.029%
8/15/2024	The Manufacturers Life Insurance Company	274,850	$13.10M	0.0%	+12.2%	0.188%
8/15/2024	Millennium Management LLC	128,215	$6.11M	0.0%	-78.0%	0.088%
8/14/2024	Squarepoint Ops LLC	436,818	$20.82M	0.0%	-41.4%	0.299%
8/14/2024	Cubist Systematic Strategies LLC	35,311	$1.68M	0.0%	-87.3%	0.024%
8/14/2024	Point72 DIFC Ltd	4,694	$0.22M	0.0%	-83.5%	0.003%
8/14/2024	Great Point Partners LLC	330,000	$15.73M	3.0%	N/A	0.226%
8/14/2024	Marshall Wace LLP	173,199	$8.26M	0.0%	+1,021.5%	0.119%
8/14/2024	Logos Global Management LP	300,000	$14.30M	1.1%	N/A	0.206%
8/14/2024	Farallon Capital Management LLC	4,800	$0.23M	0.0%	-99.3%	0.003%
8/14/2024	Xponance Inc.	18,115	$0.86M	0.0%	+11.8%	0.012%
8/14/2024	Bank of Montreal Can	220,518	$10.52M	0.0%	-37.5%	0.151%
8/14/2024	DRW Securities LLC	50,956	$2.43M	0.1%	N/A	0.035%
8/14/2024	Itau Unibanco Holding S.A.	767	$37K	0.0%	N/A	0.001%
8/14/2024	ProShare Advisors LLC	9,011	$0.43M	0.0%	-11.8%	0.006%
8/14/2024	Profund Advisors LLC	29,983	$1.43M	0.1%	-5.0%	0.021%
8/13/2024	Ensign Peak Advisors Inc	68,270	$3.25M	0.0%	+28.0%	0.047%
8/13/2024	Granite Investment Partners LLC	114,090	$5.44M	0.2%	-1.8%	0.078%
8/13/2024	Public Employees Retirement Association of Colorado	15,589	$0.74M	0.0%	-5.9%	0.011%
8/12/2024	Hsbc Holdings PLC	5,326	$0.25M	0.0%	N/A	0.004%
8/12/2024	Blair William & Co. IL	25,262	$1.20M	0.0%	-9.3%	0.017%
8/12/2024	Vanguard Personalized Indexing Management LLC	7,624	$0.36M	0.0%	+3.5%	0.005%
8/12/2024	Amalgamated Bank	9,657	$0.46M	0.0%	+4.9%	0.007%
8/12/2024	E Fund Management Co. Ltd.	10,255	$0.49M	0.0%	+4.4%	0.007%
8/9/2024	Renaissance Technologies LLC	249,514	$11.89M	0.0%	+38.8%	0.171%
8/9/2024	Dimensional Fund Advisors LP	88,746	$4.23M	0.0%	-18.8%	0.061%
8/8/2024	Envestnet Asset Management Inc.	77,415	$3.69M	0.0%	-46.6%	0.053%
8/8/2024	State of New Jersey Common Pension Fund D	55,349	$2.64M	0.0%	-32.4%	0.038%
8/8/2024	Nicollet Investment Management Inc.	20,108	$0.96M	0.4%	-2.0%	0.014%
8/6/2024	Quest Partners LLC	1,373	$65K	0.0%	-40.2%	0.001%
8/6/2024	Candriam S.C.A.	948,266	$45.19M	0.3%	+4.0%	0.650%
8/5/2024	Private Advisor Group LLC	46,426	$2.21M	0.0%	-3.2%	0.032%
8/5/2024	Arizona State Retirement System	36,722	$1.75M	0.0%	+3.5%	0.025%

Data available starting January 2016

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.

Today's Range

Now: $37.68

$37.25

$38.32

50 Day Range

MA: $37.52

$33.73

$40.36

52 Week Range

Now: $37.68

$33.33

$54.44

Volume

1,408,704 shs

Average Volume

1,340,631 shs

Market Capitalization

$5.95 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of Ionis Pharmaceuticals?: Ionis Pharmaceuticals' top insider investors include:
Brett P Monia (CEO)
Elizabeth L Hougen (CFO)
Richard S Geary (EVP)
B Lynne Parshall (Director)
C Frank Bennett (EVP)
Patrick R O'neil (EVP)
Eugene Schneider (EVP)
Brian Birchler (EVP)
Eric Swayze (EVP)
Onaiza Cadoret-Manier (EVP)
Joseph Klein III (Director)
Joseph Baroldi (EVP)
Allene M Diaz (Director)
Learn More about top insider investors at Ionis Pharmaceuticals.
Who are the major institutional investors of Ionis Pharmaceuticals?: Ionis Pharmaceuticals' top institutional shareholders include:
Bellevue Group AG — 4.99%
Geode Capital Management LLC — 1.69%
Charles Schwab Investment Management Inc. — 0.91%
ARK Investment Management LLC — 0.95%
Two Sigma Advisers LP — 0.84%
Groupama Asset Managment — 0.58%
Learn More about top institutional investors of Ionis Pharmaceuticals stock.
Which institutional investors are selling Ionis Pharmaceuticals stock?: In the last quarter, IONS stock was sold by these institutional investors:
Bellevue Group AG
Baillie Gifford & Co.
Sphera Funds Management LTD.
Great Point Partners LLC
Stifel Financial Corp
Walleye Capital LLC
Algert Global LLC
Connor Clark & Lunn Investment Management Ltd.
In the previous year, company insiders that have sold Ionis Pharmaceuticals company stock include:
Brett P Monia (CEO)
Elizabeth L Hougen (CFO)
Richard S Geary (EVP)
B Lynne Parshall (Director)
C Frank Bennett (EVP)
Patrick R O'neil (EVP)
Eugene Schneider (EVP)
Brian Birchler (EVP)
Eric Swayze (EVP)
Onaiza Cadoret-Manier (EVP)
Joseph Klein III (Director)
Learn More investors selling Ionis Pharmaceuticals stock.
Which institutional investors are buying Ionis Pharmaceuticals stock?: During the last quarter, IONS stock was purchased by institutional investors including:
International Assets Investment Management LLC
Baker BROS. Advisors LP
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
Barclays PLC
Jacobs Levy Equity Management Inc.
HBK Investments L P
abrdn plc